Glaucoma market generates around $7 billion USD each year,...

Glaucoma market generates around $7 billion USD each year, it's a pretty big niche! Sure that includes drugs, but the bull thesis here is that the interventional glaucoma management trend will continue to gain momentum and the ineffective daily drugs will be swapped for highly efficacious less frequent minimally invasive surgical options. Thus thesis is becoming more and more likely, considering that "interventional glaucoma management" seems to be the most commonly used term at recent conferences and a very popular conversation topic amongst ophthalmologists.

Plus the idea that having a niche is a bad thing is quite ridiculous and really makes me question those fundies. It's common knowledge that having a niche often generates monster profit margins (which is something I suspect we will see with EYE in the not too distant future)